1. Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Issue 6 (10th July 2017) Authors: Plantinga, TS; Arts, P; Knarren, GH; Mulder, AH; Wakelkamp, IM; Hermus, AR; Joosten, LA; Netea, MG; Bisschop, PH; de Herder, WW; Beijers, HJ; de Bruin, IJ; Gilissen, C; Veltman, JA; Hoischen, A; Smit, JW; Netea‐Maier, RT Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 6(2017) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗